Article Text

PDF

SAT0242 Anakinra increases days of work and domestic activity in patients with rheumatoid arthritis
  1. B Bresnihan1,
  2. WW Chan2,
  3. JM Woolley2
  1. 1Department of Rheumatology, St Vincent’s University Hospital, Dublin, Ireland
  2. 2Amgen, Inc., Thousand Oaks, USA

Abstract

Objectives To evaluate the effect of anakinra treatment on days of work and domestic activity in patients with rheumatoid arthritis (RA).

Methods In a six-month, placebo-controlled study conducted in Europe, 473 patients with RA were randomised to receive anakinra 30, 75 or 150 mg/day or placebo. Days of work and domestic activity were evaluated at baseline and after 4, 8, 12, 16, 20, and 24 weeks of therapy using an economic resource survey. The total days of work and domestic activity gained after commencing treatment were quantified as productivity and compared in patients receiving placebo or anakinra.

Results Patients receiving anakinra demonstrated greater gains in productivity for all doses examined (see table). These gains occurred rapidly, with over a two-day gain by week 8, and over 13 days gained on completion of the study. Furthermore, at the end of the study, an additional 14% of patients receiving anakinra did not miss any work or domestic activity, compared to 6% receiving placebo (data not shown) Table 1. Productivity (Work and Domestic Activity) Days Gained:

Abstract SAT0242 Table 1

Conclusion Patients receiving anakinra treatment experienced rapid and dose-related increases in days of work and domestic activity.

Statistics from Altmetric.com

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.